IL6 and infectious otitis media: In addition to increased cell proliferation and inflammation, we detected significantly increased serum levels of IL-6 in TLR2−/− mice at early stages of tumorigenesis after initial AOM-DSS treatment (day 14) compared to WT mice (p<0.05) (Figure 5A).